Mentice’s CEO Göran Malmberg to present the company’s interim report at a webcast conference call on April 28 at 9:30 CET
Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Elisabet Lund.
To register for the presentation of the interim report for the period January – March 2021, which will be held on April 28 at 9.30 CET, visit www.mentice.com/financial-reports-presentations
The presentation will be held in English. Participants are advised to register at least a few minutes in advance.
For further information, please contact:
Göran Malmberg, CEO, Mentice
Tel US: +1 (312) 860 5610
Tel Sweden: +46 (0) 703 09 22 22
Market place: Nasdaq First North Premier, Stockholm | Ticker symbol: MNTC
Certified Adviser: FNCA Sweden AB, tel +46 8 528 00 399 e-post firstname.lastname@example.org
Mentice (STO: MNTC) is the world leader in software and hardware simulation solutions for endovascular therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com